Pharmaceuticals, Biotechnology and Life Sciences
Holders representing approximately 62% of total Debentures extend Forbearance Period until March 14, 2022 to allow negotiations to continueTORONTO, March…
V-Bio Ventures has announced the completion the acquisition of its portfolio company Syndesi Therapeutics SA by AbbVie (NYSE: ABBV), which…
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier,…
– CatalYm receives International Nonproprietary Name (INN) visugromab for CTL-002 as approved by the World Health Organization MUNICH–(BUSINESS WIRE)–CatalYm today…
National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain has granted emergency use authorization for Valneva’s inactivated, adjuvanted COVID-19…
Pharma companies didn’t want to comment effects of the sanctions against Russia.
Heidelberg Pharma and Huadong Medicine have entered into a strategic partnership with the signing of an exclusive licensing agreement as…
Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, have announced that the European Medicines Agency’s (EMA) CHMP has recommended…
Vivoryon Therapeutics a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group have announced that…
Abzena, a partner research organization for integrated services from discovery through to clinical and commercial manufacturing for biologics and bioconjugates,…